Biotech Industry Faces Revival as FDA Issues Loom in 2026
Biotech investors can expect a significant shift in the market landscape in 2026, according to industry expert Bruce Booth, a partner at Atlas Venture. His insights indicate that after two…
New Gonorrhea Drug Approved: A Major Scientific and Business Leap
A significant advancement in the fight against drug-resistant infections emerged last week with the approval of two new oral antibiotics by the U.S. Food and Drug Administration (FDA). Among them…
FDA Approves Daily Libido Pill for Postmenopausal Women
The U.S. Food and Drug Administration (FDA) has approved a daily pill designed to enhance libido among postmenopausal women, extending access to those up to the age of 65. This…
FDA Approves Addyi for Women Over 65 to Boost Libido
The U.S. Food and Drug Administration (FDA) has expanded the approval of the libido-boosting drug Addyi, allowing its use for women over the age of 65 who have undergone menopause.…
FDA Approves Three New Treatments for Hereditary Angioedema in 2025
Hereditary angioedema (HAE), a rare genetic condition characterized by recurrent and unpredictable swelling attacks, is receiving unprecedented attention in 2025 due to the rapid approval of three new treatments by…
Medical Device Recalls Surge: Key Issues Identified by FDA
The U.S. Food and Drug Administration (FDA) reported that over 2,500 medical device recalls are issued annually in the United States. These recalls can range from simple inspections to the…
Bidding War Heats Up for Metsera’s PD-(L)1xVEGF Bispecific Therapy
The competition for Metsera’s PD-(L)1xVEGF bispecific therapy has intensified, prompting significant interest from major pharmaceutical companies. This race represents a critical moment in the development of innovative cancer treatments, as…
FDA Faces Pressure to Keep Pace with Advances in Cancer Treatment
Patients and their families are increasingly calling on the U.S. Food and Drug Administration (FDA) to adapt its regulatory policies to align with rapid advancements in cancer treatments. Many individuals,…
Grail’s Blood Test Improves Cancer Detection Ahead of FDA Filing
Grail’s innovative blood test has shown significant improvement in accurately identifying true cancer cases, according to findings presented at the ESMO25 conference in October 2023. This development could bolster the…
Kezar Life Sciences Explores Strategic Options After FDA Setback
Kezar Life Sciences has announced its intent to explore strategic alternatives following a setback with the U.S. Food and Drug Administration (FDA). This move comes after the FDA declined to…